Scarica l'app Stockscreener
128.75
5.71%
-7.80
Dopo l'orario di chiusura:
128.75
Protagonist Therapeutics Inc Azioni (PTGX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
278.72%
213.47
|
56.37 | 7.437 | 4.712 | 5.546 |
| Operating Expenses |
8.84%
54.71
|
60.02 | 57.79 | 51.13 | 47.59 |
| Operating Income/Loss |
4,452%
158.77
|
-3.648 | -50.35 | -46.42 | -42.04 |
| Income/Loss From Continuing Operations Before Tax |
7,139%
165.11
|
2.281 | -43.72 | -39.34 | -34.60 |
| Income Tax Expense/Benefit |
250.80%
2.265
|
-1.502 | 0.666 | - | 0.172 |
| Net Income/Loss |
4,205%
162.85
|
3.783 | -44.38 | -39.34 | -34.77 |
| Basic Average Shares |
1.30%
65.94
|
65.09 | 0.1545 | 63.77 | 63.51 |
| Diluted Average Shares |
0.73%
71.01
|
70.49 | 0.1545 | 63.77 | 63.51 |
| Basic Earnings Per Share |
4,017%
2.47
|
0.06 | -0.70 | -0.62 | -0.55 |
| Diluted Earnings Per Share |
4,480%
2.29
|
0.05 | -0.70 | -0.62 | -0.55 |
3.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):